The multifunctional protein E4F1 links P53 to lipid metabolism in adipocytes
-
Published:2021-12
Issue:1
Volume:12
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Lacroix MatthieuORCID, Linares Laetitia K., Rueda-Rincon Natalia, Bloch Katarzyna, Di Michele Michela, De Blasio CarloORCID, Fau Caroline, Gayte Laurie, Blanchet Emilie, Mairal Aline, Derua Rita, Cardona FernandoORCID, Beuzelin Diane, Annicotte Jean-SebastienORCID, Pirot Nelly, Torro Adeline, Tinahones Francisco J., Bernex Florence, Bertrand-Michel Justine, Langin DominiqueORCID, Fajas LluisORCID, Swinnen Johannes V.ORCID, Le Cam LaurentORCID
Abstract
AbstractGrowing evidence supports the importance of the p53 tumor suppressor in metabolism but the mechanisms underlying p53-mediated control of metabolism remain poorly understood. Here, we identify the multifunctional E4F1 protein as a key regulator of p53 metabolic functions in adipocytes. While E4F1 expression is upregulated during obesity, E4f1 inactivation in mouse adipose tissue results in a lean phenotype associated with insulin resistance and protection against induced obesity. Adipocytes lacking E4F1 activate a p53-dependent transcriptional program involved in lipid metabolism. The direct interaction between E4F1 and p53 and their co-recruitment to the Steaoryl-CoA Desaturase-1 locus play an important role to regulate monounsaturated fatty acids synthesis in adipocytes. Consistent with the role of this E4F1-p53-Steaoryl-CoA Desaturase-1 axis in adipocytes, p53 inactivation or diet complementation with oleate partly restore adiposity and improve insulin sensitivity in E4F1-deficient mice. Altogether, our findings identify a crosstalk between E4F1 and p53 in the control of lipid metabolism in adipocytes that is relevant to obesity and insulin resistance.
Funder
Agence Nationale de la Recherche Institut National Du Cancer Ligue Contre le Cancer Fondation ARC pour la Recherche sur le Cancer Institut National de la Santé et de la Recherche Médicale
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference51 articles.
1. Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Rev. Cancer 14, 359–370 (2014). 2. Kastenhuber, E. R. & Lowe, S. W. Putting p53 in context. Cell 170, 1062–1078 (2017). 3. Lacroix, M., Riscal, R., Arena, G., Linares, L. K. & Le Cam, L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol. Metab. 33, 2–22 (2020). 4. Labuschagne, C. F., Zani, F. & Vousden, K. H. Control of metabolism by p53 - cancer and beyond. BBA - Rev. Cancer 1870, 32–42 (2018). 5. Blandino, G., Valenti, F., Sacconi, A. & Di Agostino, S. Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease. Semin. Cell Dev. Biol. 98, 105–117 (2020).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|